Can You Heard That Pregnancy Treat Endometriosis?FFragrant
In some women, endometriosis symptoms will be relieved after pregnancy. However, some patients may have difficulty in pregnancy. For these patients, they need to be treated before they become pregnant, such as herbal medicine Fuyan Pill.
Can You Heard That Pregnancy Treat Endometriosis?FFragrant
In some women, endometriosis symptoms will be relieved after pregnancy. However, some patients may have difficulty in pregnancy. For these patients, they need to be treated before they become pregnant, such as herbal medicine Fuyan Pill.
Can Increased Hot Water Intake Alleviate Painful Menstruation.pptxFFragrant
Increased hot water intake can alleviate painful menstruation. However, when it is related to some disease, like adenomyosis, natural medicine Fuyan Pill can be a nice option.
Can Increased Hot Water Intake Alleviate Painful Menstruation.pptxFFragrant
Increased hot water intake can alleviate painful menstruation. However, when it is related to some disease, like adenomyosis, natural medicine Fuyan Pill can be a nice option.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
2. Now there are an increasing number of patients
with gynecological diseases. The key is that
women do not pay much attention to their living
habits. Coupled with increasing pressure, women
have no more time to take care of their bodies.
3. For example, adenomyosis is a gynecological
disease with a relatively high incidence. Women
who have given birth to children are more likely
to suffer from this disease, even though some
are older and near menopause. At this time,
many women think that adenomyosis might
cause no more symptoms after menopause.
5. To answer this question, women should understand
the pathogenesis of adenomyosis. Adenomyosis
occurs mainly as an endogenous endometriosis, in
which active endometrial cells are planted in the
myometrium. With menstrual bleeding, the clinical
manifestation is dysmenorrhea, the uterus is
diffusely enlarged, and the menstrual flow can be
heavy. In other words, adenomyosis is closely related
to the phenomenon of female menstruation.
6. After menopause, the secretion of various
hormones in the body is reduced. Adenomyosis
is an estrogen-dependent disease. After
menopause, women's ovaries no longer secrete
estrogen, and the estrogen in the body is at a
low level for a long time.
7. Besides, the endometrium will atrophy, and the
uterus will atrophy too. This will cause
myometrial gland lesions to shrink, symptoms to
alleviate, and even some mild adenomyosis may
gradually heal. This gives some women the
illusion that the disease will go away on its own
after menopause.
8. In fact, though the symptoms of the disease
disappear, it does not mean that adenomyosis has
gone away. Generally speaking, the lesions that have
formed in the myometrium of the patient are
unlikely to disappear with menopause of the
patient. The pathological basis is still there, so there
is still the possibility of recurrence in the future.
9. At the same time, because the ovaries are not the
only organ that secretes estrogen in the female
body, some patients may even secrete hormones
from other organs after menopause and continue
stimulating the growth of lesions and producing
pain.
10. So women with adenomyosis should not take it lightly
after menopause. Although the disease may not
affect the sufferer's daily life, it is essential to have a
regular physical examination once or twice a year.
Only through the re-examination of the physical
examination can women know on time whether there
are other lesions, so they can also treat abnormal
conditions as soon as they notice them.
11. If it is in the early stage, the general monitoring
of the tumor size can be ok. Without the support
of hormones in the body, most legions will not
continue to grow. If women go through
menopause, they no longer have a menstrual
cycle and no longer feel the stimulation of
endometrial growth.
12. However, it is still recommended that female
patients follow the doctor's advice and carry out the
systematic and scientific treatment. Antibiotics can
be used to remove adenomyosis-related lesions in
the body. If the drug effect is not good, surgery is
needed for treatment.
13. In short, the patient's health is the starting point of
all treatments. Women can choose the herbal
medicine Fuyan Pill under the guidance of doctors,
which can effectively kill bacteria, eliminate
inflammation and relieve women's pain.
14. Women are also recommended to eat less cold and
spicy foods daily. They should also pay attention to
abdominal warmth. Do not overwork and stay up
late. At the same time, women should strengthen
their body resistance through exercise, which is
conducive to recovery from disease and the
maintenance of physical health.
15. If you have questions about your condition
and treatment, contact our experts. Most
questions are answered in 24 hours.
wuhandrli@gmail.com
herbalistlee@yahoo.com
wuhandrlee@hotmail.com